ID

34664

Description

Study ID:103812 & 104727 Clinical Study ID:103812 & 104727 Study Title: Study to assess safety and reactogenicity of booster dose of either an investigational vaccination regimen or DTPw-HBV/Hib when administered at 15 to 18 months of age and of a dose of Mencevax ACWY vaccine. Patient Level Data:N/A Clinicaltrials.gov Identifier:N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Haemophilus influenzae Type b Vaccine Trade Name: Tritanrix HepB/Hiberix Study Indication: Diphtheria; Haemophilus influenzae type b; Hepatitis B; Tetanus; Whole Cell Pertussis

Mots-clés

Versions (2)
  1. 22/01/2019 22/01/2019 -
  2. 22/01/2019 22/01/2019 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

22 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Safety and reactogenicity of booster dose of either an investigational vaccination regimen or DTPw HBVHib 103812 & 104727

Anglais

103812 (DTPW-HBV=HIB-MENAC-TT-014 BST:013&004 (15-18M)) - Medication; Non- Serious Adverse Events; Study Conclusion

1 Formulaires  
Medication
Description

Medication

Alias
UMLS CUI-1
C0013227
Has any medications/ treatments been administered during study period?
Description

If yes, please complete the following table.

Type de données

boolean

Alias
UMLS CUI [1]
C3469597
Medication
Description

Medication

Alias
UMLS CUI-1
C0013227
Trade/ Generic Name
Description

Trade/ Generic Name

Type de données

text

Alias
UMLS CUI [1]
C2360065
UMLS CUI [2]
C0592502
Medical Indication
Description

Medical Indication

Type de données

integer

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0013227
Total daily dose
Description

Total daily dose

Type de données

text

Alias
UMLS CUI [1,1]
C2348070
UMLS CUI [1,2]
C0439810
Medication Administration route
Description

Medication Administration route

Type de données

text

Alias
UMLS CUI [1]
C0013153
Medication Start Date
Description

Medication Start Date

Type de données

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0808070
Medication End Date
Description

Medication End Date

Type de données

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0806020
Medication continuing at end of study
Description

Medication continuing at end of study

Type de données

integer

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0549178
UMLS CUI [2,1]
C0008976
UMLS CUI [2,2]
C0444930
Non- serious Adverse Event
Description

Non- serious Adverse Event

Alias
UMLS CUI-1
C1518404
Has any non- serious adverse event occured within one month (minimum 30 days) post- vaccination, excluding those recorded on the Solicited Adverse Events pages?
Description

Has any non- serious adverse event occured within one month post- vaccination?

Type de données

boolean

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C2368628
UMLS CUI [1,3]
C0687676
Non- serious Adverse Event
Description

Non- serious Adverse Event

Alias
UMLS CUI-1
C1518404
Non- serious adverse event Description
Description

Non- serious adverse event Description

Type de données

text

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0678257
Administration site or Non- administration site?
Description

Administration site or Non- administration site?

Type de données

text

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0013153
UMLS CUI [1,3]
C0042210
Start Date Non- serious Adverse Event
Description

Start Date Non- serious Adverse Event

Type de données

date

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0808070
Start Date Non- serious Adverse Event during immediate post- vaccination period (30 minutes)?
Description

Start Date Non- serious Adverse Event during immediate post- vaccination period (30 minutes)?

Type de données

boolean

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0808070
UMLS CUI [1,3]
C2368628
UMLS CUI [1,4]
C0687676
Stop Date Non- serious Adverse Event
Description

Stop Date Non- serious Adverse Event

Type de données

date

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0806020
Non- serious Adverse Event Intensity
Description

Non- serious Adverse Event Intensity

Type de données

integer

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0518690
Relationship to investigatoinal products
Description

Is there a reasonable possibility that the AE may have been caused by the investigational product?

Type de données

boolean

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0013230
UMLS CUI [1,3]
C0439849
Non- serious Adverse Event Outcome
Description

Non- serious Adverse Event Outcome

Type de données

integer

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C1705586
Medically attended visit
Description

If yes, please specify type.

Type de données

boolean

Alias
UMLS CUI [1,1]
C0545082
UMLS CUI [1,2]
C1386497
Medically attended visit specification
Description

Medically attended visit specification

Type de données

text

Alias
UMLS CUI [1,1]
C0545082
UMLS CUI [1,2]
C1386497
UMLS CUI [1,3]
C2348235
Study Conclusion
Description

Study Conclusion

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
Did the subject experience any Serious Adverse Event during the study period?
Description

Did the subject experience any Serious Adverse Event during the study period?

Type de données

boolean

Alias
UMLS CUI [1]
C1519255
If subject experiences Serious Adverse Event, specify total number of Serious Adverse Events
Description

Total number of Serious Adverse Events

Type de données

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0449788
Did any elimination criteria become applicable during the study?
Description

Did any elimination criteria become applicable during the study?

Type de données

boolean

Alias
UMLS CUI [1]
C0680251
Specify elimination criteria
Description

Specify elimination criteria

Type de données

text

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C2348235
Was the subject withdrawn from study?
Description

Was the subject withdrawn from study?

Type de données

boolean

Alias
UMLS CUI [1]
C0422727
Please tick the ONE most appropriate category for withdrawal
Description

Please tick the ONE most appropriate category for withdrawal

Type de données

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0392360
If reason for withdrawal is Non- serious Adverse Event, specify.
Description

If reason for withdrawal is Non- serious Adverse Event, specify.

Type de données

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0392360
UMLS CUI [2]
C1518404
If reason for withdrawal is protocol violation, specify
Description

If reason for withdrawal is protocol violation, specify

Type de données

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0392360
UMLS CUI [2]
C1709750
If other reason for withdrawal, specify
Description

If other reason for withdrawal, specify

Type de données

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0205394
UMLS CUI [1,4]
C2348235
Please tick, who took decision
Description

Please tick, who took decision

Type de données

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0679006
Date of last contact
Description

Date of last contact

Type de données

date

Alias
UMLS CUI [1]
C0805839
Was the subject in good condition at date of last contact?
Description

If no, please give details within the Adverse Events section.

Type de données

boolean

Alias
UMLS CUI [1,1]
C1142435
UMLS CUI [1,2]
C0681850
UMLS CUI [1,3]
C0805839
Investigator's signature
Description

Investigator's signature

Alias
UMLS CUI-1
C2346576
Investigator's signature
Description

I confirm that I have reviewed the date in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.

Type de données

text

Alias
UMLS CUI [1]
C2346576
Printed Investigator's name
Description

Printed Investigator's name

Type de données

text

Alias
UMLS CUI [1]
C2826892
Investigator's signature date
Description

Investigator's signature date

Type de données

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Retour au début de la page

Similar models

103812 (DTPW-HBV=HIB-MENAC-TT-014 BST:013&004 (15-18M)) - Medication; Non- Serious Adverse Events; Study Conclusion

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Medication
C0013227 (UMLS CUI-1)
Has any medications/ treatments been administered during study period?
Item
Has any medications/ treatments been administered during study period?
boolean
C3469597 (UMLS CUI [1])
Item Group
Medication
C0013227 (UMLS CUI-1)
Trade/ Generic Name
Item
Trade/ Generic Name
text
C2360065 (UMLS CUI [1])
C0592502 (UMLS CUI [2])
Item
Medical Indication
integer
C3146298 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Medical Indication
Code List
Medical Indication
CL Item
Prophylactic (1)
Total daily dose
Item
Total daily dose
text
C2348070 (UMLS CUI [1,1])
C0439810 (UMLS CUI [1,2])
Medication Administration route
Item
Medication Administration route
text
C0013153 (UMLS CUI [1])
Medication Start Date
Item
Medication Start Date
date
C0013227 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Medication End Date
Item
Medication End Date
date
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
Medication continuing at end of study
integer
C0013227 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
C0008976 (UMLS CUI [2,1])
C0444930 (UMLS CUI [2,2])
Medication continuing at end of study
Code List
Medication continuing at end of study
CL Item
Medication continuing (1)
Item Group
Non- serious Adverse Event
C1518404 (UMLS CUI-1)
Has any non- serious adverse event occured within one month post- vaccination?
Item
Has any non- serious adverse event occured within one month (minimum 30 days) post- vaccination, excluding those recorded on the Solicited Adverse Events pages?
boolean
C1518404 (UMLS CUI [1,1])
C2368628 (UMLS CUI [1,2])
C0687676 (UMLS CUI [1,3])
Item Group
Non- serious Adverse Event
C1518404 (UMLS CUI-1)
Non- serious adverse event Description
Item
Non- serious adverse event Description
text
C1518404 (UMLS CUI [1,1])
C0678257 (UMLS CUI [1,2])
Item
Administration site or Non- administration site?
text
C1515974 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
Administration site or Non- administration site?
Code List
Administration site or Non- administration site?
CL Item
Administration site (L)
CL Item
Non- administration site (G)
Start Date Non- serious Adverse Event
Item
Start Date Non- serious Adverse Event
date
C1518404 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Start Date Non- serious Adverse Event during immediate post- vaccination period (30 minutes)?
Item
Start Date Non- serious Adverse Event during immediate post- vaccination period (30 minutes)?
boolean
C1518404 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
C2368628 (UMLS CUI [1,3])
C0687676 (UMLS CUI [1,4])
Stop Date Non- serious Adverse Event
Item
Stop Date Non- serious Adverse Event
date
C1518404 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
Non- serious Adverse Event Intensity
integer
C1518404 (UMLS CUI [1,1])
C0518690 (UMLS CUI [1,2])
Non- serious Adverse Event Intensity
Code List
Non- serious Adverse Event Intensity
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
Relationship to investigatoinal products
Item
Relationship to investigatoinal products
boolean
C1518404 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
Item
Non- serious Adverse Event Outcome
integer
C1518404 (UMLS CUI [1,1])
C1705586 (UMLS CUI [1,2])
Non- serious Adverse Event Outcome
Code List
Non- serious Adverse Event Outcome
CL Item
Recovered/ Resolved (1)
CL Item
Recovering/ Resolving (2)
CL Item
Not recovered/ not resolved (3)
CL Item
Recovered with sequelae/ Resolved with sequelae (4)
Medically attended visit
Item
Medically attended visit
boolean
C0545082 (UMLS CUI [1,1])
C1386497 (UMLS CUI [1,2])
Item
Medically attended visit specification
text
C0545082 (UMLS CUI [1,1])
C1386497 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Medically attended visit specification
Code List
Medically attended visit specification
CL Item
Hospitalisation  (HO)
CL Item
Emergency Room (ER)
CL Item
Medical Personnel (MD)
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Did the subject experience any Serious Adverse Event during the study period?
Item
Did the subject experience any Serious Adverse Event during the study period?
boolean
C1519255 (UMLS CUI [1])
Total number of Serious Adverse Events
Item
If subject experiences Serious Adverse Event, specify total number of Serious Adverse Events
integer
C1519255 (UMLS CUI [1,1])
C0449788 (UMLS CUI [1,2])
Did any elimination criteria become applicable during the study?
Item
Did any elimination criteria become applicable during the study?
boolean
C0680251 (UMLS CUI [1])
Specify elimination criteria
Item
Specify elimination criteria
text
C0680251 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Was the subject withdrawn from study?
Item
Was the subject withdrawn from study?
boolean
C0422727 (UMLS CUI [1])
Item
Please tick the ONE most appropriate category for withdrawal
text
C0422727 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Please tick the ONE most appropriate category for withdrawal
Code List
Please tick the ONE most appropriate category for withdrawal
CL Item
Serious adverse event (SAE)
CL Item
Non- serious adverse event (complete Non- serious Adverse Event section), please specify (AEX)
CL Item
Protocol violation, please specify (PTV)
CL Item
Consent withdrawal, not due to an adverse event (CWS)
CL Item
Migrated/ moved from the study area (MIG)
CL Item
Lost to follow- up (LFU)
CL Item
Other, please specify (OTH)
If reason for withdrawal is Non- serious Adverse Event, specify.
Item
If reason for withdrawal is Non- serious Adverse Event, specify.
text
C0422727 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C1518404 (UMLS CUI [2])
If reason for withdrawal is protocol violation, specify
Item
If reason for withdrawal is protocol violation, specify
text
C0422727 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C1709750 (UMLS CUI [2])
If other reason for withdrawal, specify
Item
If other reason for withdrawal, specify
text
C0422727 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
Item
Please tick, who took decision
text
C0422727 (UMLS CUI [1,1])
C0679006 (UMLS CUI [1,2])
Please tick, who took decision
Code List
Please tick, who took decision
CL Item
Investigator (I)
CL Item
Parents/ Guardians (P)
Date of last contact
Item
Date of last contact
date
C0805839 (UMLS CUI [1])
Was the subject in good condition at date of last contact?
Item
Was the subject in good condition at date of last contact?
boolean
C1142435 (UMLS CUI [1,1])
C0681850 (UMLS CUI [1,2])
C0805839 (UMLS CUI [1,3])
Item Group
Investigator's signature
C2346576 (UMLS CUI-1)
Investigator's signature
Item
Investigator's signature
text
C2346576 (UMLS CUI [1])
Printed Investigator's name
Item
Printed Investigator's name
text
C2826892 (UMLS CUI [1])
Investigator's signature date
Item
Investigator's signature date
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial